Gromit Therapeutics Announces an Exclusive License Agreement with the Icahn School of Medicine at Mount Sinai
Gromit Therapeutics, a clinical-stage biopharmaceutical company, developing disruptive gene therapies for inflammatory and age related diseases, and the Icahn School of Medicine at Mount Sinai in New York , NY (“Icahn Mount Sinai”) have announced today an exclusive license agreement to the …
1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patients
Late-breaking data presented at American Diabetes Association Scientific Sessions® demonstrates increased adherence to care guidelines for physicians using KidneyIntelX risk assessment to improve outcomes, alleviate patient suffering, and reduce significant financial burden associated with rapidly progressing chronic kidney disease. Deployment of Renalytix’s …
Mount Sinai Elementa Labs: First Year in Review
Take a look at the exciting updates from the inaugural year of Elementa Labs, Mount Sinai’s virtual incubator program. Elementa Labs is currently accepting new applications for the Spring 2023 cohort until August 1. Learn more and apply here. In May 2021, …
Renalytix Announces Two Data Presentations on KidneyIntelX™ at American Diabetes Association 82nd Scientific Sessions®
Real-world clinical utility in 1,112 patients tested with KidneyIntelX. KidneyIntelX stratification for cardiovascular risk in 1,278 diabetic kidney disease patients Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced its participation at the American Diabetes Association (ADA) 82nd Scientific Sessions® meeting in New Orleans from …
Q&A: Spinovations, a Pitch Challenge 2022 Finalist, Discusses Improving Spinal Surgery One Screw at a Time
Meet Spinovations, a team from Mount Sinai developing a screwdriver to enable minimally invasive spinal procedures. Spinovations will be pitching this technology at the annual Pitch Challenge on May 5! This team won the Innovation Showcase on April 20, where the Pitch …
Q&A: Meet Tyree Williams, a Pitch Challenge 2022 Finalist Developing a Cement Leakage Prevention System for Spinal Surgeries
Tyree Williams’ team is developing a mortar bone cement system to prevent cement leakage during spinal surgery. Williams will be presenting this technology at the Mount Sinai Pitch Challenge on May 5! Have you registered for the Mount Sinai Pitch Challenge? Sign …
Meet Faris Gulamali of CPP.ai, a Pitch Challenge 2022 Finalist
Tune in below as Faris Gulamali describes CPP.ai, a non-invasive real-time artificial intelligence (AI) tool to monitor cerebral perfusion pressure. Gulamali will be presenting this technology at the Mount Sinai Pitch Challenge on May 5! Have you registered for the Mount Sinai …
Q&A: Meet Jihan Ryu and Xiaosi Gu of Trustworthy Voice, a Pitch Challenge 2022 Finalist
Jihan Ryu and Xiasi Gu are the co-founders of Trustworthy Voice, an artificial intelligence (AI) platform to track patient-clinician alliance. Ryu and Gu will be presenting this technology at the Mount Sinai Pitch Challenge on May 5! Have you registered for the …
Q&A: Meet Jason Adleberg, a Pitch Challenge 2022 Finalist
Get to know Jason Adleberg, who is developing an artificial intelligence (AI) software program to detect aortic aneurysms. Adleberg will be presenting this technology at the Mount Sinai Pitch Challenge on May 5! Have you registered for the Mount Sinai Pitch Challenge? …